Tesamorelin is a synthetic peptide known as an analogue of the natural growth hormone-releasing hormone. It consists of forty-four amino acids and, with certain modification, mimics the properties of the parent compound. However, this formulation is significantly more resistant to degradation and achieves better clinical results. Its primary function is reflected in the reduction of abdominal visceral fat, especially in HIV-positive patients. Additionally, scientists believe that it can be used to treat neurodegenerative diseases due to its positive effects on cognitive function. By increasing the secretion of growth hormone and stimulating lipolysis, it can potentially be used as part of an obesity therapy.
Dosing Chart
|
Timeline |
First 6 weeks |
6 – 12 weeks |
|
Protocol for reducing visceral abdominal fat in HIV-positive patients. |
1mg (one subcutaneous injection daily) |
2mg (one subcutaneous injection daily) |
About the Peptide
There are certain modifications in the chemical structure and properties compared to the original compound, which make this peptide more potent, effective, and safer for the patient.
HIV-positive patients are immunodeficient because they have a large number of CD4+ lymphocytes. These patients often suffer from fungal, viral, and bacterial infections. Therapy consists mainly of long-term antiviral therapy because HIV infection is a viral disease. However, this therapy carries with it numerous risks, such as an increase in visceral abdominal fat, loss of subcutaneous fat (mainly in the extremities), and sometimes even gynecomastia (the appearance of female breasts in men). In addition to aesthetic problems, these are serious complications because they carry a high risk of developing cardiovascular disease, insulin resistance, and even psychiatric conditions such as anxiety or depression.
The basic mechanism of action of Tesamorelin, which achieves an effective reduction of visceral abdominal fat, is reflected in the stimulation of growth hormone secretion (since this peptide is an analogue of human natural growth hormone). In addition, this peptide stimulates lipolysis (the process of breaking down fat deposits). An essential part of the effectiveness is reflected in the reduced volume of abdominal fat without a significant reduction in muscle mass. The patient, therefore, remains equally mobile and functional, but without the risk of developing serious diseases.
Scientific studies have demonstrated that Tesamorelin exhibits specific effects in terms of improving cognitive function. This property is crucial because HIV-positive patients, even when long-term therapy is applied that keeps them mentally stable, develop in a large number of cases various neurocognitive disorders (HIV-associated neurocognitive disorders). As a result of these disorders, a decline in cognitive functions occurs, including memory, attention, focus, language, and many other cognitive abilities. Scientists believe that this peptide can improve verbal memory, perception, and understanding of information. In addition, in cases of bacterial or viral meningitis and encephalitis (which are common), Tesamorelin can reduce inflammation and act as an anti-inflammatory and neuroprotective agent.

List of Uses
Reduction of Visceral Abdominal Fat in HIV-positive Patients
HIV infection is a viral infection that, in its final stages, is known as AIDS. It is also known as acquired immunodeficiency syndrome, because the main mechanism of action of this virus after entering the cell is the destruction of CD4+ lymphocytes. These cells are the primary carriers of immunity, as they are cytotoxic and kill all microorganisms upon entering the body.
When its level drops significantly, the patient's immunity also drops significantly, and they become susceptible to all microbial infections (viral, fungal, bacterial, and others). The patient is at risk of infection if he has unprotected sexual intercourse because the virus is primarily transmitted through bodily fluids such as semen or vaginal secretions. In addition, intravenous drug users are a very high-risk group, given that HIV can also be transmitted through blood products. Other risk factors may include the use of non-sterile instruments during tattooing, piercing, or dental procedures.
The disease is severe and progresses with age. However, in today's medical practice, there is a daily therapy that keeps the patient as protected as possible from microbial infections. One of the most commonly used treatments is antiretroviral therapy. It has shown relatively good results in patients in different stages of HIV infection. However, it carries significant side effects and risks of developing various diseases.
One of the common side effects of therapy is the accumulation of abdominal visceral fat. The most common locations are on the upper and lower extremities. In addition to aesthetic problems that can lead to psychiatric problems (anxiety and depression), the development of this disorder is significant because it increases the risk of cardiovascular diseases and insulin resistance. Tesamorelin is an analogue of natural growth hormone that stimulates the release of this hormone.
This origin gives it the ability to act by stimulating the synthesis of growth hormone, thereby directly stimulating lipolysis (the process of breaking down fat in the liver). In addition, there is a direct stimulation of the synthesis of IGF-1 (Insulin-like Growth Factor 1). This hormone is similar in structure to insulin and acts in conjunction with growth hormones.
The great advantage of the action of this peptide is the reduction of intra-abdominal volume, without reducing the volume of muscle mass. Patients remain mobile and vital as much as the stage of the disease allows.
Improving Cognitive Functions and Neuroprotective Effect
During the disease, patients usually develop neurodegenerative diseases with a decrease in cognitive functions. HIV-associated neurocognitive disorders are a group of severe disorders that can lead to impaired attention, memory, focus, and perception of received information. Tesamorelin has a neuroprotective effect, increasing the level of the previously described IGF. Based on its mechanisms of action, verbal memory, attention, and accelerated processing of acquired information are improved. Inflammatory conditions such as meningitis, encephalitis, and meningoencephalitis of bacterial and viral forms are prevalent in cases of HIV infection. In this case, Tesamorelin can help reduce inflammatory processes and accelerate recovery.
Dosing Calculator
The dosage of the peptide, as always, depends on the indication. However, in this case, the peptide is most often used in HIV-positive patients for the reduction of abdominal visceral fat. For this indication, Tesamorelin is administered subcutaneously at a dose of 1 mg once daily for the first six weeks. This dose is less therapeutically effective, but serves to acclimate the patient to the therapy and reduce the likelihood of side effects. For the next six weeks, the peptide is administered at a dose of 2 mg, which is the maximum dose. The maximum recommended dose should not be exceeded in order to avoid serious adverse effects.
Conclusion
Tesamorelin is a synthetic peptide and is an analogue of natural growth hormone. As such, it achieves numerous beneficial effects, the most famous of which is the reduction of visceral abdominal fat in HIV-positive patients. Since neurological diseases often occur in these patients, the peptide can also enhance cognitive functions and exhibit a neuroprotective effect, which can significantly improve their overall condition and reduce the possibility of side effects.
